48
Participants
Start Date
December 28, 2020
Primary Completion Date
June 26, 2021
Study Completion Date
September 2, 2021
CCH-aaes
Participants were administered CCH-aaes by subcutaneous injection to both buttocks.
Compression
Participants used a compression garment on both buttocks following subcutaneous CCH-aaes injections.
Cold Packs
Participants used cold packs applied to the right buttock for 5-10 minutes immediately after subcutaneous CCH-aaes injections.
Arnica Gel
Participants used Arnica Gel Patches (Arnica montana 50% and Ledum palustre) immediately after the CCH-aaes injection to the right buttock.
INhance®
Participants used INhance Post-injection Serum topically immediately after the CCH-aaes injection to the right buttock.
PDL
Investigators applied one treatment with PDL to the right buttock between days 1-7 after injection.
Endo Clinical Trial Site #4, Nashville
Endo Clinical Trial Site #5, Chicago
Endo Clinical Trial Site #1, Shreveport
Endo Clinical Trial Site #6, Fort Collins
Endo Clinical Trial Site #3, Scottsdale
Endo Clinical Trial Site #7, San Diego
Endo Clinical Trial Site #2, Sacramento
Endo Clinical Trial Site #8, Boston
Lead Sponsor
Collaborators (1)
DeNova Research
OTHER
University of California, San Diego
OTHER
The Wall Center for Plastic Surgery
OTHER
Mathew Avram, MD
UNKNOWN
Laser & Skin Surgery Medical Group, Inc.
OTHER
Investigate MD, LLC
OTHER
Biesman, Brian, M.D.
INDIV
Plastic Surgical Associates of Fort Collins, P.C.
OTHER
Endo Pharmaceuticals
INDUSTRY